US 8932818
Screening assays for compounds that modulate programmed ribosomal frameshifting
granted A61KA61K31/4035A61P
Quick answer
US patent 8932818 (Screening assays for compounds that modulate programmed ribosomal frameshifting) held by PTC THERAPEUTICS, INC. expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/4035, A61P, A61P31/12, A61P43/00